Disclosed is a pharmaceutical composition comprising (a) tumour cells which are apoptotic caused by treatment with high hydrostatic pressure equal to or greater than 100 MPa for 10 minutes to 2 hours and (b) dendritic cells. Also disclosed are therapeutic relating to the use of the composition as a cancer vaccine.